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WALLACE AND McKNIGHT BRIEF DEFINITIVE REPORT described previously (8) . A carotid artery was cannulated for intra-arterial administration of the leukotrienes . The leukotrienes were administered via this route so that first-pass clearance by the liver and lung could be avoided . Effects on Susceptibility to Injury. At the beginning of the experiment, a blood sample (75 ul) was taken from the carotid cannula for determination ofresting hematocrit . Each experiment consisted of six 10-min periods, with the solution bathing the mucosa (5.0 ml) being changed at the beginning of each period . During all periods except the third, the mucosa was bathed with 50 mM hydrochloric acid made isosmotic with mannitol. During the third period, the mucosa was "challenged" with 20% ethanol (vol/vol) . All luminal bathing solutions were warmed to 37°C before being added to the chamber. At the end of each period, the luminal bathing solution was removed by syringe, weighed, then frozen for subsequent determination ofprotein concentration (9) . An intra-arterial infusion ofone ofthe leukotrienes or the vehicle was started at minute 17 (i.e., 3 min before the challenge with 20% ethanol) and was continued for 5 min. The following leukotrienes were tested : leukotrienes C4, D4, C5, and D5 . Leukotrienes C4 and D4 were tested at doses of 0.1, 1, and 3 ug/kg/min, while leukotrienes Cs and D5 were tested at doses of 1, 3, and 5 /~g/kg/min. At the end of the experiment, a second blood sample was taken from the carotid cannula for determination of hematocrit. The mucosa was photographed using color transparency film for subsequent planimetric determination of the surface area of the mucosa that exhibited hemorrhage (8) .
Effects on Gastric BloodFlow. The rats were anesthetized and an ex vivo chamber was prepared, as described above. Gastric blood flow was measured using a laser-Doppler flowmeter, as has been described in detail elsewhere (10) . A hard-tip pencil probe (P-431 ; TSI Inc., St. Paul, MN) was mounted in a micromanipulator over the chamber preparation . The probe was connected to a flowmeter (BPM 403A; TSI Inc.) for continuous recording ofgastric blood flow. The probe was lowered onto the mucosal surface, and basal recordings were made for at least 20 min. The site of placement of the probe was random, except that it was always placed within the corpus region . Blood flow was recorded continuously, and basal readings were taken for at least 15 min before any leukotriene was tested . Each ofthe four leukotrienes used in the studies described above were infused intra-arterially for a total of3 min. For LTC4 and LTD4, the doses tested were 0.05, 0.1, and 1 gg/kg/min . For LTC5 and LTD5, the doses tested were 0.1, 1, 2, and 5 ,ug/kg/min. After infusing one of the leukotrienes, gastric blood flow was allowed to return to basal levels before another test was started . The order oftesting of the different leukotrienes and doses within a preparation were randomized. Each dose of each leukotriene was tested in at least four separate preparations .
Statistical Analysis. All data are expressed as the mean t SEM . Comparisons between groups of data were made using the student's t test, with the exception of the changes in hematocrit, where a paired t test was used.
Materials. All leukotrienes were kindly provided by Dr. A. W Ford-Hutchinson of MerckFrosst Research Laboratories . The leukotrienes were stored in aliquots at -70°C. On the day ofan experiment, an aliquot was thawed and then diluted appropriately in PBS (pH 7.4) .
Results
Effects on Susceptibility to Injury. The resting transmucosal potential difference (PD) ranged between 45 and 55 mV (mucosa negative to serosa) in all experiments . In control rats receiving intra-arterial PBS, the topical application of ethanol caused a decrease in the PD of -30 mV followed by a gradual return to basal levels . By the end of the experiment, 30 min after removal of 20% ethanol from the chamber, the PD in the control group had recovered to 96 t 6% of basal levels . Hemorrhagic erosions formed during the 30-min period after the challenge with 20% ethanol, but were limited to the periphery of the chamber, and involved <1% of the total glandular mucosa . The application of ethanol resulted in a marked increase in the concentration of protein in the luminal bathing fluid, but in subsequent periods the amount of protein efflux returned towards basal levels .
Intra-arterial infusion of LTC4 or LTD4 at a dose of 0.1 hg/kg/min did not significantly affect any of the three parameters of mucosal damage, when compared with the control group. However, when infused at doses of 1 or 3 /Ag/kg/min, both LTC4 and LTD4 produced significant increases in hemorrhagic damage area (Fig .  1) and protein efflux into the luminal solution (Fig . 2) . Furthermore, the transmucosal PD in rats receiving intra-arterial LTC4 or LTD4 at these doses did not return to basal levels by the end of the experiment (Fig. 3 ) . Significant differences between Extent of hemorrhagic damage to the gastric mucosa induced by topically applied 20% ethanol and intra-arterially infused leukotrienes . Each leukotriene was infused, at the doses shown, for 5 min. In the control group receiving the vehicle intra-arterially, the damage area involved <1% of the total glandular mucosa . Each point represents the mean f SEM of at least four experiments.
-0 LTC4 ence values for groups of rats that received aleu- the effects of similar doses of LTC4 and LTD4 were not observed with any of the three parameters of damage . Intra-arterial infusion of LTC5 or LTD5 at doses of 1 or 3 Ag/kg/min did not significantly affect hemorrhagic damage area, the efflux of protein into the lumen, or the recovery of transmucosal PD after topical application of 20% ethanol (Figs .  1-3) . At a dose of 5 Wg/kg/min, both of the EPA-derived leukotrienes significantly increased hemorrhagic damage area and protein efflux, while only LTC5 significantly affected the recovery of PD towards basal levels.
Marked differences between the AA-and EPA-derived leukotrienes were also observed when their effects on hematocrit were examined. For example, LTC4 and LTD4 produced small, but significant (;6 < 0.05), increases in hematocrit at a dose of 3 hg/kg/min (9 .6 ± 1 .5 0 Io and 12.3 t 3 .2%, respectively) . On the other hand, LTC5 and LTD5 did not produce significant changes in hematocrit at any of the doses tested .
Effects on Gastric Blood Flow.
Intra-arterial infusions of LTC4 or LTD4 for 3 min produced marked reductions in gastric blood flow at doses of 0.1 or 1 Ag/kg/min (Fig. 4) . While there were not significant differences between the magnitude of the reduction in blood flow with the two AA-derived leukotrienes, only LTD4 produced a statistically significant reduction of flow at the dose of 0.1 wg/kg/min. At the dose of 1 hg/kg/min, the two AA-derived leukotrienes reduced gastric blood flow by 40-60%.
Infusion of the two leukotrienes derived from EPA, at doses of 0.1, 1, or 2 Wg/kg/min, did not significantly alter gastric blood flow (Fig. 4) . At a dose of 5 Jig/kg/min, both LTC5 and LTD5 produced significant decreases in flow, and there was no significant difference between the two leukotrienes in terms of the magnitude of the reduction of flow.
Discussion
Numerous studies have implicated a role for peptido-leukotrienes in the pathogenesis of experimental gastric ulceration (1) . While a link has never been conclusively made, it is presumed that the vasoconstrictor actions of these leukotrienes in the gastric submucosa are responsible for the observed ability of these compounds to increase the susceptibility ofthe gastric mucosa to injury. It has further been suggested that effects of peptido-leukotrienes on vascular permeability may contribute to their "pro-ulcerogenic" actions (3) . Effects of intra-arterial infusion of various leukotrienes (for 3 min) on gastric blood flow. Blood flow was measured by laser-Doppler flowmetry, and the changes in blood flow as shown represent the difference (percentage) between preinfusion and post-infusion levels . LTC4 significantly (p < 0 .05) reduced gastric blood flow at doses of 0 .1 and 1 hg/kg/min ; LTD4 significantly reduced flow at a dose of 1 14g/kg/min . LTC5 and LTD5 only produced a significant reduction of gastric blood flow when infused at the 5 /Lg/kg/min dose . Each point represents the mean ± SEM of at least four experiments .
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Very little is known of the actions of the peptido-leukotrienes derived from EPA in vivo, in particular, their actions on the stomach. Most previous studies on EPA have focused on LTB4 vs . LTB5 (2, 11, 12) , although there are also data from in vitro studies of smooth muscle contractility to suggest that LTC5 is less potent as an agonist than LTC4 (13) . A number of recent studies have been performed in which the effects of fish oil diets on the resistance of the gastric mucosa to injury have been assessed (3) (4) (5) (6) (7) . An underlying assumption of these studies is that the fish oil diet modifies eicosanoid production such that prostaglandins with more potent protective actions and/or leukotrienes with less potent pro-ulcerogenic actions are produced . The results of the present study show that there is indeed a clear difference in the potency of leukotrienes derived from AA vs . those from EPA. Regardless of which index of mucosal damage is used (i .e ., damage area, protein efflux, PD), a similar pattern was observed . There were also marked differences in potency between the AA-and EPA-derived leukotrienes in terms of their effects on gastric blood flow. LTC4 and LTD4 were at least five times more potent than LTC5 and LTD5 . It seems likely that the changes in blood flow induced by the leukotrienes are an important component of the mechanism of action of increasing susceptibility to injury by 20% ethanol. It is possible, however, that other actions of these leukotrienes contributed to the increased susceptibility to damage observed after their administration .
It should be noted that the addition of significant quantities of fish oil or pure EPA to a diet will undoubtedly affect the synthesis of many other products besides leukotrienes . Whether or not changes in the synthesis of prostaglandins may explain the observations of increased mucosal resistance to injury has not yet been determined, although one group has reported that an EPA-derived prostaglandin (PGF3«) is, in fact, less potent as a protective agent than its AA-derived counterpart (PGF2a) (14) . Clearly, further studies are required not only to clarify the role of leukotrienes in experimental and human gastrointestinal ulceration, but also to clarify the mechanism through which the addition of EPA or fish oil to the diet results in increased resistance of the gastroduodenal mucosa to injury.
Summary
The ability of leukotrienes derived from eicosapentaenoic acid were compared with counterpart leukotrienes derived from arachidonic acid in terms of their ability to affect susceptibility of the stomach to injury induced by a topical irritant and their ability to alter gastric blood flow. Intra-arterial infusion of leukotriene C4 (LTC4) and LTD4 (0 .1-3 Fig/kg/min for 5 min) produced dose-dependent increases in gastric mucosal damage induced by topically applied 20% ethanol, as assessed macroscopically, by changes in transmucosal potential difference and by measurement of efflux of protein into the gastric lumen . Similar doses of LTC5 or LTD5 did not produce significant changes in any of these three parameters, when compared with control rats receiving the vehicle. With a higher dose of LTC5 or LTD5 (5 Nag/kg/min), significant damage was observed . LTC4 and LTD4 were also found to be more potent at reducing gastric blood flow than LTC5 and LTD5 . These results demonstrate that the peptido-leukotrienes derived from eicosapentaenoic acid (LTC5 and LTD5) are on the order of five times less potent than the leukotrienes derived from arachidonic acid (LTC4 and LTD4), in terms of increasing the susceptibility of the gastric mucosa to damage and reducing gastric blood flow. These 
